Pharmaceutical compositions are provided for the treatment of disorders in a subject, such as hypertension, congestive heart failure, angina pectoris, lower urinary tract dysfunction and prostatic hypertrophy. The compositions when administered to a subject produce an .alpha.-adrenergic blocking action and contain as an active ingredient sulfamoyl-substituted phenethylamine derivatives, such as optically active 5-2-[2-(2-ethoxyphenoxy)ethylamino]-2-methylethyl-2-methoxybenzenesulfonam ide, and a pharmaceutically acceptable carrier.
提供了用于治疗主题中的疾病(例如高血压、充血性心力衰竭、心绞痛、下尿路功能障碍和前列腺肥大)的药物组合物。当给主题施用该组合物时,会产生α-
肾上腺素受体阻滞作用,其活性成分为磺酰基取代的苯
乙胺衍
生物,例如光学活性的5-2-[2-(2-乙氧基苯氧基)乙基
氨基]-2-甲基乙基-2-
甲氧基苯磺酰胺,以及药用载体。